Munar Pharma

Munar Pharma FCF/Debt

Delisted

The Free Cash Flow to Debt Ratio of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -260.06 %. In the previous year, Free Cash Flow to Debt Ratio was 81.32 % — a change of -419.80% (lower).

FCF/Debt

-260.06 %

YoY

-419.80%

Last updated:

Free Cash Flow to Debt Ratio of Munar Pharma is 2024 -260.06 % . Free Cash Flow to Debt Ratio of Munar Pharma was 2023 81.32 % . It decreases by -419.80% lower compared to the previous year.

The Munar Pharma FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2016
10.49 PLN
Jan 1, 2017
-983.39 PLN
Jan 1, 2018
-1,059.51 PLN
Jan 1, 2019
-130.79 PLN
Jan 1, 2020
-906.94 PLN
Jan 1, 2021
-8,958.51 PLN
Jan 1, 2023
81.32 PLN
Jan 1, 2024
-260.06 PLN
The Munar Pharma FCF/Debt history
YEARFCF/DebtYoY
-260.06 %-419.80%
81.32 %-100.91%
-8,958.51 %+887.78%
-906.94 %+593.44%
-130.79 %-87.66%
-1,059.51 %+7.74%
-983.39 %-9,471.87%
10.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

Free Cash Flow to Debt Ratio of Munar Pharma is -260.06 % in 2024.

Free Cash Flow to Debt Ratio of Munar Pharma changed from 81.32 % to -260.06 %, representing a -419.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Munar Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Munar Pharma

All Key Metrics — Munar Pharma